Obesity in Cardiorenal syndrome: Management Opportunities and Challenges. [PDF]
Reaves A, Jaffe E, McCallum W.
europepmc +1 more source
Protein C deficiency in a uremic patient: a rare case of multivessel thromboembolism and type 5 cardiorenal syndrome. [PDF]
Ying Q +10 more
europepmc +1 more source
1-Methylhistidine attenuates early myocardial inflammation in type 3 cardiorenal syndrome through modulation of the p105/p50 NF-κB axis. [PDF]
Zhang J +5 more
europepmc +1 more source
Cardiorenal Syndrome in a Kidney Transplant Recipient With High-Flow Arteriovenous Fistula and Mycotic Pneumonia. [PDF]
Broda J +4 more
europepmc +1 more source
Nature's Bioactives in Cardiorenal Syndrome: Polyphenols at the Crossroads-Preclinical Insights into Redox, Inflammation, and Mitochondrial Protection. [PDF]
Carollo C +9 more
europepmc +1 more source
Experimental rodent models of cardiorenal syndrome types 3 and 4: Insights and clinical relevance (Review). [PDF]
Figueroa SM +6 more
europepmc +1 more source
Editorial: Hypertension and cardiorenal syndrome and their relationship with aging: friends and foes. [PDF]
Muzi-Filho H, Vieyra A.
europepmc +1 more source
Albumin-corrected anion gap and mortality risk in cardiorenal syndrome: Insights from a nationally representative cohort study. [PDF]
Li H +8 more
europepmc +1 more source
Renal Biomarkers and Albuminuria Predict Early Adverse Outcomes in Cardiorenal Syndrome Type 2. [PDF]
Bećirović M +8 more
europepmc +1 more source

